The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PKTX | -42.2% | -93.96% | -42.96% | +40% |
| S&P | +16.9% | +95.99% | +14.39% | +483% |
Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company was founded by Grant Young on December 23, 1999 and is headquartered in Dalton, OH.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.01M | 1.1% |
| Market Cap | $3.38M | -4.2% |
| Net Income | -$0.09M | -7.0% |
| EBITDA | -$0.08M | -8.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $0.00M | -94.9% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | 0.0% |
| Short Term Debt | $0.00M | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -79.30% | -0.6% |
| Return On Invested Capital | -623.28% | 128.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$0.08M | 1.0% |
| Operating Free Cash Flow | -$0.08M | 1.0% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 9.30 | 9.35 | 13.15 | 8.88 | -0.57% |
| Price to Tangible Book Value | -69.57 | -45.30 | -35.24 | -32.94 | -40.13% |
| Enterprise Value to EBITDA | -56.13 | -41.30 | -52.66 | -39.39 | -19.76% |
| Return on Equity | -90.2% | -93.6% | -96.0% | -101.6% | 19.21% |
| Total Debt | $0.00M | $0.00M | $0.00M | $0.00M | - |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
